pyrroles has been researched along with fluconazole in 10 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (20.00) | 29.6817 |
2010's | 7 (70.00) | 24.3611 |
2020's | 1 (10.00) | 2.80 |
Authors | Studies |
---|---|
Bäcklund, T; Kahri, J; Kivistö, KT; Valkonen, M; Vuoristo, M | 1 |
Arora, SK; Jain, S; Jana, GH; Sinha, N | 1 |
Bruggisser, M; Franz, CC; Krähenbühl, S; Rätz Bravo, AE | 1 |
Bilitewski, U; Burakowska, A; Buschart, A | 1 |
Casadevall, A; Chatterjee, S; Fernandes, C; Gonçalves, T; Nakouzi-Naranjo, A; Prados-Rosales, R; Silva, BM; Stark, RE; Zuzarte, M | 1 |
Chen, XY; Gong, Y; Hou, XY; Peng, WX; Zhang, YF; Zhong, DF; Zhu, RH; Zuo, CZ | 1 |
Li, X; Sha, J; Sun, L; Tong, Z; Wang, C; Yang, X; Zhang, G; Zhou, K | 1 |
Dong, X; Fu, N; Hu, Y; Lv, X; Wang, L; Weng, L; Xue, L; Yang, D; Yang, N | 1 |
Bautista-Crescencio, C; Chamorro-Cevallos, G; Escalante, CH; Gonzalez-Silva, A; Hernández-Rodríguez, C; Madrigal-Aguilar, DA; Ortiz-Álvarez, J; Rosales-Acosta, B; Sánchez-Navarrete, J; Tamariz, J; Villa-Tanaca, L | 1 |
Ismail, S; Küchler, P; Murarka, S; Nussbaumer, P; Schultz-Fademrecht, C; Triola, G; Waldmann, H; Wittinghofer, A; Zimmermann, G | 1 |
10 other study(ies) available for pyrroles and fluconazole
Article | Year |
---|---|
Rhabdomyolysis in a patient receiving atorvastatin and fluconazole.
Topics: Antifungal Agents; Atorvastatin; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme Inhibitors; Drug Synergism; Fatal Outcome; Fluconazole; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Male; Middle Aged; Mycoses; Pyrroles; Rhabdomyolysis | 2005 |
Synthesis of some diguanidino 1-methyl-2,5-diaryl-1H-pyrroles as antifungal agents.
Topics: Antifungal Agents; Aspergillus; Candida; Drug Resistance, Microbial; Fluconazole; Guanidine; Microbial Sensitivity Tests; Pyrroles; Structure-Activity Relationship | 2005 |
[Rhabdomyolysis associated with atorvastatin combined with amiodarone and fluconazole].
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Anticholesteremic Agents; Antifungal Agents; Atorvastatin; Coronary Artery Bypass, Off-Pump; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inhibitors; Dose-Response Relationship, Drug; Drug Interactions; Drug Therapy, Combination; Fluconazole; Heptanoic Acids; Humans; Kidney Failure, Chronic; Male; Metabolic Clearance Rate; Middle Aged; Postoperative Complications; Pyrroles; Rhabdomyolysis | 2011 |
The fungicide fludioxonil antagonizes fluconazole activity in the human fungal pathogen Candida albicans.
Topics: Antifungal Agents; ATP-Binding Cassette Transporters; Candida albicans; Candidiasis; Cell Proliferation; Dioxoles; Drug Resistance, Fungal; Fluconazole; Fungal Proteins; Fungicides, Industrial; Gene Expression Regulation, Fungal; Histidine Kinase; Humans; Membrane Transport Proteins; Microbial Sensitivity Tests; Protein Kinases; Pyrroles; Rhodamines | 2012 |
Activation of Melanin Synthesis in Alternaria infectoria by Antifungal Drugs.
Topics: Alternaria; Aminoglycosides; Amphotericin B; Antifungal Agents; Caspofungin; Cell Wall; Echinocandins; Fluconazole; Itraconazole; Lipopeptides; Melanins; Microbial Sensitivity Tests; Naphthols; Pyrroles; Quinolines | 2015 |
Effect of Fluconazole on the Pharmacokinetic Properties of Imrecoxib, a Novel NSAID: A Single-center, Open-label, Self-controlled Study in Healthy Chinese Male Volunteers.
Topics: Administration, Oral; Adult; Antifungal Agents; Area Under Curve; China; Cross-Over Studies; Cyclooxygenase 2 Inhibitors; Drug Interactions; Fluconazole; Healthy Volunteers; Humans; Male; Pyrroles; Random Allocation; Sulfides; Young Adult | 2018 |
Enhancing the colorimetric detection of H
Topics: Ascorbic Acid; Biomimetic Materials; Biosensing Techniques; Catalysis; Colorimetry; Fluconazole; Humans; Hydrogen Peroxide; Kinetics; Limit of Detection; Metal-Organic Frameworks; Models, Chemical; Peroxidase; Polymers; Pyrroles | 2019 |
A lipase-responsive antifungal nanoplatform for synergistic photodynamic/photothermal/pharmaco-therapy of azole-resistant Candida albicans infections.
Topics: Animals; Antifungal Agents; Azoles; Candida albicans; Candidiasis; Drug Resistance, Fungal; Ethylene Glycols; Fluconazole; Ketones; Lasers; Lipase; Mice; Nanoparticles; Photochemotherapy; Phototherapy; Polyesters; Pyrroles | 2019 |
Antifungal Activity of Fibrate-Based Compounds and Substituted Pyrroles That Inhibit the Enzyme 3-Hydroxy-methyl-glutaryl-CoA Reductase of
Topics: Acyl Coenzyme A; Animals; Antifungal Agents; Candida glabrata; COVID-19; Drug Resistance, Fungal; Ergosterol; Fibric Acids; Fluconazole; Humans; Hydroxymethylglutaryl CoA Reductases; Microbial Sensitivity Tests; Pandemics; Pyrroles | 2022 |
Structure guided design and kinetic analysis of highly potent benzimidazole inhibitors targeting the PDEδ prenyl binding site.
Topics: Atorvastatin; Benzimidazoles; Binding Sites; Cell Line, Tumor; Computer Simulation; Cyclic Nucleotide Phosphodiesterases, Type 6; Drug Design; Esters; Ethers; Heptanoic Acids; Humans; Kinetics; Models, Molecular; Protein Prenylation; Pyrroles; ras Proteins; Stereoisomerism; Structure-Activity Relationship; Thermodynamics | 2014 |